Frances Meredith Hocutt

Title: Frances Meredith Hocutt: Innovator in Pharmaceutical Chemistry

Introduction

Frances Meredith Hocutt is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 8 patents. Her work focuses on developing innovative compounds and methods that address various medical conditions.

Latest Patents

One of her latest patents is titled "Benzoimidazoles as prolyl hydroxylase inhibitors." This invention is directed to benzoimidazole compounds and their enantiomers, diastereomers, racemates, and pharmaceutically acceptable salts. These compounds are particularly useful in pharmaceutical compositions and methods for treating diseases and disorders modulated by prolyl hydroxylase activity. Another notable patent is "Reagents and methods for screening MPS I, II, IIIA, IIIB, IVA, VI, and VII." This patent includes reagents, methods, and kits for assaying enzymes associated with lysosomal storage diseases, specifically MPS-I, MPS-II, MPS-IIIA, MPS-IIIB, MPS-IVA, MPS-VI, and MPS-VII.

Career Highlights

Frances has worked with reputable organizations such as Janssen Pharmaceutica and the University of Washington. Her experience in these institutions has allowed her to advance her research and contribute to the development of important pharmaceutical solutions.

Collaborations

Some of her notable coworkers include Barry Eastman Leonard, Jr. and Michael H. Rabinowitz. Their collaborative efforts have further enhanced the impact of her inventions in the pharmaceutical field.

Conclusion

Frances Meredith Hocutt is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in medical treatments. Her innovative patents and collaborations reflect her commitment to improving healthcare through scientific research.